Boston Scientific Corporation (BSX) recently entered into a definitive agreement to acquire Bolt Medical, Inc. — an intravascular lithotripsy (IVL) advanced laser-based platform developer. The acquisition will expand Boston Scientific’s cardiovascular portfolio with Bolt IVL — a complementary and differentiated calcium modification platform.Boston Scientific anticipates the transaction to be completed in the first half of 2025, subject to customary closing conditions.Likely Trend of BSX Stock Following the ...